tradingkey.logo

West Pharmaceutical Services Inc

WST
272.440USD
+3.780+1.41%
收盘 12/19, 16:00美东报价延迟15分钟
19.59B总市值
40.12市盈率 TTM

West Pharmaceutical Services Inc

272.440
+3.780+1.41%

关于 West Pharmaceutical Services Inc 公司

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

West Pharmaceutical Services Inc简介

公司代码WST
公司名称West Pharmaceutical Services Inc
上市日期Sep 01, 2059
CEOGreen (Eric Mark)
员工数量10600
证券类型Ordinary Share
年结日Sep 01
公司地址530 Herman O. West Drive
城市EXTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编19341
电话16105942900
网址https://www.westpharma.com/
公司代码WST
上市日期Sep 01, 2059
CEOGreen (Eric Mark)

West Pharmaceutical Services Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+11.41%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+34.90%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+98.08%
Ms. Janet Brutschea Haugen
Ms. Janet Brutschea Haugen
Independent Director
Independent Director
1.56K
+216.80%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%
地区USD
名称
营收
占比
Europe Middle East and Africa
352.59M
46.00%
Americas
344.93M
45.00%
Asia Pacific
68.98M
9.00%
业务
地区
业务USD
名称
营收
占比
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
其他
69.50%
持股股东
持股股东
占比
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
其他
69.50%
股东类型
持股股东
占比
Investment Advisor
48.04%
Investment Advisor/Hedge Fund
32.14%
Hedge Fund
6.92%
Pension Fund
4.01%
Research Firm
2.24%
Bank and Trust
1.82%
Sovereign Wealth Fund
1.37%
Insurance Company
0.76%
Endowment Fund
0.62%
其他
2.09%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1640
70.77M
98.37%
-2.34M
2025Q2
1636
72.03M
100.16%
-1.82M
2025Q1
1662
71.25M
99.16%
-2.66M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
9.28M
12.91%
+83.24K
+0.90%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
5.27%
-358.56K
-8.65%
Jun 30, 2025
State Street Investment Management (US)
3.27M
4.55%
+68.33K
+2.13%
Jun 30, 2025
Artisan Partners Limited Partnership
2.27M
3.15%
+71.84K
+3.27%
Jun 30, 2025
Brown Advisory
3.02M
4.2%
-247.19K
-7.56%
Jun 30, 2025
Walter Scott & Partners Ltd.
2.20M
3.06%
-142.10K
-6.07%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.83M
2.55%
-20.69K
-1.12%
Jun 30, 2025
Van Eck Associates Corporation
1.49M
2.07%
+38.34K
+2.65%
Jun 30, 2025
APG Asset Management N.V.
1.66M
2.31%
+96.53K
+6.18%
Jun 30, 2025
Durable Capital Partners LP
1.04M
1.45%
-532.47K
-33.85%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Motley Fool Mid-Cap Growth ETF
3.52%
VanEck Morningstar Wide Moat ETF
2.83%
First Trust Indxx Medical Devices ETF
2.15%
VanEck Morningstar Wide Moat Value ETF
2.14%
Invesco S&P 500 Equal Weight Health Care ETF
1.8%
Nuveen ESG Mid-Cap Growth ETF
1.72%
American Century Mid Cap Growth Impact ETF
1.63%
Hilton Small-MidCap Opportunity ETF
1.51%
iShares Health Innovation Active ETF
1.5%
ProShares S&P 500 Dividend Aristocrats ETF
1.46%
查看更多
Motley Fool Mid-Cap Growth ETF
占比3.52%
VanEck Morningstar Wide Moat ETF
占比2.83%
First Trust Indxx Medical Devices ETF
占比2.15%
VanEck Morningstar Wide Moat Value ETF
占比2.14%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.8%
Nuveen ESG Mid-Cap Growth ETF
占比1.72%
American Century Mid Cap Growth Impact ETF
占比1.63%
Hilton Small-MidCap Opportunity ETF
占比1.51%
iShares Health Innovation Active ETF
占比1.5%
ProShares S&P 500 Dividend Aristocrats ETF
占比1.46%

分红派息

近5年累计派现 269.40M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jul 24, 2025
WST.NB Final Cash Dividend of gross USD 0.22 paid on Nov 19, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 19, 2025
Nov 12, 2025
Apr 24, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Aug 06, 2025 going ex on Jul 30, 2025
Jul 30, 2025
Aug 06, 2025
Jul 30, 2025
Feb 20, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on May 07, 2025 going ex on Apr 30, 2025
Apr 30, 2025
May 07, 2025
Apr 30, 2025
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

West Pharmaceutical Services Inc的前五大股东是谁?

West Pharmaceutical Services Inc 的前五大股东如下:
The Vanguard Group, Inc.持有股份:9.28M,占总股份比例:12.91%。
BlackRock Institutional Trust Company, N.A.持有股份:3.79M,占总股份比例:5.27%。
State Street Investment Management (US)持有股份:3.27M,占总股份比例:4.55%。
Artisan Partners Limited Partnership持有股份:2.27M,占总股份比例:3.15%。
Brown Advisory持有股份:3.02M,占总股份比例:4.20%。

West Pharmaceutical Services Inc的前三大股东类型是什么?

West Pharmaceutical Services Inc 的前三大股东类型分别是:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

有多少机构持有West Pharmaceutical Services Inc(WST)的股份?

截至2025Q3,共有1640家机构持有West Pharmaceutical Services Inc的股份,合计持有的股份价值约为70.77M,占公司总股份的98.37%。与2025Q2相比,机构持股有所增加,增幅为-1.79%。

哪个业务部门对West Pharmaceutical Services Inc的收入贡献最大?

在FY2025Q2,High Value Components业务部门对West Pharmaceutical Services Inc的收入贡献最大,创收360.25M,占总收入的47.00%。
KeyAI